AdventHealth has reached a significant milestone in its vaccine distribution efforts in communities across nine states. As of April 2021, AdventHealth has administered more than 250,000 COVID-19 vaccines.
The journey to this milestone began in December 2020, following the EUA approval of the Pfizer COVID-19 vaccine. In the months leading up to the first coronavirus vaccine’s availability, AdventHealth CEO Terry Shaw assembled a task force of the organization’s experts to plan a systemwide strategy for an efficient, safe and equitable vaccine rollout.
This number represents a huge step forward in protecting people and helping them get back to the things that make them feel whole,” said AdventHealth’s chief medical officer Brent Box, MD. “The strides being made in the rollout of this vaccine across the country contribute to what will be one of the greatest comebacks of our time.”
The impact of this vaccine was recently illustrated by a study shared by the CDC, which confirms the Pfizer and Moderna vaccines can reduce COVID-19 hospitalization risk by 94% among older adults, drastically reducing the danger of a coronavirus infection.
250,000 Vaccines: Major Milestone in Protecting Communities through AdventHealth’s Ongoing Vaccine Efforts
“This milestone is a testament to the tenacity and dedication of our teams across the country,” said Dr. Box. “We are very encouraged by our progress but know there is still much work needed to provide COVID-19 vaccines to our team members and communities as a safe and highly effective form of protection. In addition to the protection offered by vaccines, we must continue taking the evidence-based precautions that keep people safe.”
As the health system’s vaccine rollout continues, AdventHealth’s coronavirus experts recommend using trusted resources such as the Coronavirus Resources Hub and the CDC for information about COVID-19 and the vaccines available.
